1.A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors.
Brain Tumor Research and Treatment 2018;6(2):54-59
BACKGROUND: Leptomeningeal metastasis (LM) is an uncommon, but devastating complication of advanced cancer and has no standard treatment. Herein, we analyzed the clinical characteristics and outcomes of patients with solid tumors who were diagnosed with LM. METHODS: Between January 2007 and December 2017, we retrospectively analyzed the medical records of patients with solid tumors who were diagnosed with LM. RESULTS: A total of 58 patients were enrolled in this study. The median age of patients was 51 years (range, 27–72 years), and 62.1% had a poor Eastern Cooperative Oncology Group (ECOG) performance status (PS) (>2). The common types of primary tumor were breast cancer (39.7%), gastric cancer (25.9%), and non-small cell lung cancer (20.7%). Forty-two patients (72.4%) were diagnosed with LM by MRI of the brain and/or spine and cerebrospinal fluid (CSF) analysis, 14 were diagnosed by CSF analysis alone, and 2 were diagnosed by MRI alone. Treatments for LM were performed in 53 patients (91.4%), and best supportive care was provided for 5 patients (8.6%). Intrathecal chemotherapy, radiotherapy, and systemic chemotherapy were administered in 43 (74.1%), 17 (29.3%), and 24 (41.4%) patients, respectively. The median overall survival of the entire cohort was 2.4 months (95% confidence interval, 1.0–3.7). In the analysis of prognostic factors for survival, a good ECOG PS (≤2), administration of systemic chemotherapy after LM diagnosis, and a prior history of brain radiation were associated with prolonged survival. CONCLUSION: Although the prognosis of LM in patients with solid tumors is poor, systemic chemotherapy might improve survival in selected patients with a good PS.
Brain
;
Breast Neoplasms
;
Carcinoma, Non-Small-Cell Lung
;
Cerebrospinal Fluid
;
Cohort Studies
;
Diagnosis
;
Drug Therapy
;
Humans
;
Magnetic Resonance Imaging
;
Medical Records
;
Meningeal Carcinomatosis
;
Neoplasm Metastasis*
;
Prognosis
;
Radiotherapy
;
Retrospective Studies*
;
Spine
;
Stomach Neoplasms
2.Alteration of Innate Immune T and B Cells in the NC/Nga Mouse.
Jungeun KIM ; Hyojeong KIM ; Tae Yoon KIM ; Se Ho PARK ; Seokmann HONG
Immune Network 2005;5(3):137-143
BACKGROUND: Millions of people in the world are suffering from atopic dermatitis (AD), which is a chronic inflammatory skin disease triggered by Th2 immune responses. The NC/Nga mouse is the most extensively studied animal model of AD. Like human AD, NC/Nga mice demonstrate increased levels of IgE, a hallmark of Th2 immune responses. Adaptive immunity cannot be generated without help of innate immunity. Especially natural killer T (NKT) cells and marginal zone B (MZB) cells have been known to play important roles in linking innate immunity to adaptive immunity. METHODS: Through flow cytometric analysis and ELISA assay, we investigated whether these lymphocytes might be altered in number in NC/Nga mice. RESULTS: Our data demonstrated that the number of NKT cells was reduced in NC/Nga mice and IFNgamma production by NKT cells upon alpha-GalCer stimulation decreased to the levels of CD1d KO mice lacking in NKT cells. However, reduction of NKT cells in NC/Nga mice was not due to CD1d expression, which was normal in the thymus. Interestingly, there was a significant increase of CD1d(high)B220+ cells in the spleen of NC/Nga mice. Further, we confirmed that CD1d(high)B220+ cells are B cells, not dendritic cells. These CD1d(high)B220+ B cells show IgM(high)CD21(high)CD23low, a characteristic phenotype of MZB cells. CONCLUSION: We provide the evidence that there are decreased activities of NKT cells and increased number of MZB cells in the NC/Nga mice. Our findings may thus explain why NC/Nga mice are susceptible to AD.
Adaptive Immunity
;
Animals
;
B-Lymphocytes*
;
Dendritic Cells
;
Dermatitis, Atopic
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunity, Innate
;
Immunoglobulin E
;
Lymphocytes
;
Mice*
;
Models, Animal
;
Natural Killer T-Cells
;
Phenotype
;
Skin Diseases
;
Spleen
;
Thymus Gland
3.Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection.
Baraem YOO ; Hyojeong AHN ; Miseon KIM ; Dong Hoon SUH ; Kidong KIM ; Jae Hong NO ; Yong Beom KIM
Obstetrics & Gynecology Science 2017;60(5):440-448
OBJECTIVE: The purpose of this study is to estimate the risk of postoperative lymphocele development after lymphadenectomy in gynecologic cancer patients through establishing a nomogram. METHODS: We retrospectively reviewed 371 consecutive gynecologic cancer patients undergoing lymphadenectomy between 2009 and 2014. Association of the development of postoperative lymphocele with clinical characteristics was evaluated in univariate and multivariate regression analyses. Nomograms were built based on the data of multivariate analysis using R-software. RESULTS: Mean age at the operation was 50.8±11.1 years. Postoperative lymphocele was found in 70 (18.9%) patients. Of them, 22 (31.4%) had complicated one. Multivariate analysis revealed that hypertension (hazard ratio [HR], 3.0; 95% confidence interval [CI], 1.5 to 6.0; P=0.003), open surgery (HR, 3.2; 95% CI, 1.4 to 7.1; P=0.004), retrieved lymph nodes (LNs) >21 (HR, 1.8; 95% CI, 1.0 to 3.3; P=0.042), and no use of intermittent pneumatic compression (HR, 2.7; 95% CI, 1.0 to 7.2; P=0.047) were independent risk factors for the development of postoperative lymphocele. The nomogram appeared to be accurate and predicted the lymphocele development better than chance (concordance index, 0.754). For complicated lymphoceles, most variables which have shown significant association with general lymphocele lost the statistical significance, except hypertension (P=0.011) and mean number of retrieved LNs (29.5 vs. 21.1; P=0.001). A nomogram for complicated lymphocele showed similar predictive accuracy (concordance index, 0.727). CONCLUSION: We developed a nomogram to predict the risk of lymphocele in gynecologic cancer patients on the basis of readily obtained clinical variables. External validation of this nomogram in different group of patients is needed.
Female
;
Genital Neoplasms, Female
;
Humans
;
Hypertension
;
Lymph Node Excision*
;
Lymph Nodes*
;
Lymphocele*
;
Multivariate Analysis
;
Nomograms*
;
Retrospective Studies
;
Risk Factors
4.ZigBee-based Wireless Neuro-Stimulator for Improving Stroke Recovery.
Gookhwa KIM ; Hyojeong YUN ; Munho RYU ; Yongil SHIN ; Hyoungihl KIM ; Yoonseok YANG
Experimental Neurobiology 2010;19(3):165-172
Stroke is a leading cause of adult disability and the second-leading cause of death in Korea. It is also the third-leading cause of death in the United States, leading to a serious demand for new interventions to improve the quality of life in stroke survivors. To this end, direct cortical stimulation using an epidural electrode has been reported with promising results in animal and human studies, showing the potential for enhancing the recovery in chronic stroke patients. For optimal results, doctors must be able to modify the stimulation pattern as frequently as needed over a period of time for a given patient. However, severe aftereffects caused by stroke limit patients' activities, making regular doctor visits for treatment difficult. This study aims to develop a prototype of a telemedicine system to enhance stroke recovery by using a ZigBee-based wireless neuro-stimulator. The ZigBee is a stable platform for many low-power wireless applications. To allow stroke patients to remotely obtain neuro-stimulation treatments from their doctors, we connected the ZigBee to the internet. The system also allows doctors to personalize treatment based on the history of the stimulation parameters. The system developed here can also be beneficial as a common platform for a wide range of brain diseases and clinical care for which electric stimulation is used.
Adult
;
Animals
;
Brain Diseases
;
Cause of Death
;
Electric Stimulation
;
Electrodes
;
Humans
;
Internet
;
Korea
;
Quality of Life
;
Stroke
;
Survivors
;
Telemedicine
;
United States
5.Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib.
Hyojeong KIM ; Tak YUN ; Young Joo LEE ; Ji Youn HAN ; Heung Tae KIM ; Geon Kook LEE
Journal of Korean Medical Science 2013;28(11):1595-1602
Most patients with tyrosine kinase inhibitor (TKI)-sensitive non-small cell lung cancer (NSCLC) eventually develop acquired resistance to TKIs. Factors that affect TKI-sensitive patient survival after progression during TKI treatment remain unknown. We attempted to identify factors that affected post-progression survival. We retrospectively reviewed 81 advanced NSCLC patients with disease progression following tumor response and durable (> or = 6 months) disease stabilization with first-line or second-line gefitinib. Post-progression survival (PPS) and characteristics were investigated and compared in patients who did (n = 16) and did not (n = 65) resume TKIs. Most patients were female never-smokers with adenocarcinoma. Median overall PPS was 10.3 months (95% confidence interval [CI], 7.458-13.142). Age, gender, smoking history, histology, Eastern Cooperative Oncology Group performance status at gefitinib initiation, initial stage, and platinum-based chemotherapy after gefitinib were not significant predictors of PPS. Pemetrexed use after gefitinib significantly improved PPS (18.5 vs 8.6 months; hazard ratio [HR], 0.45; P = 0.008). Gefitinib reuse tended to lengthen PPS but was insignificant in multivariate analysis (27.4 vs 8.8 months; HR, 0.53; P = 0.095). NSCLC patients assumed to have clinically acquired resistance to TKIs had relatively long PPS. TKIs reuse or pemetrexed use after progression with gefitinib may improve PPS.
Adenocarcinoma/drug therapy/*mortality
;
Adult
;
Aged
;
Aged, 80 and over
;
Antineoplastic Agents/therapeutic use
;
Carcinoma, Non-Small-Cell Lung/drug therapy/*mortality
;
Disease-Free Survival
;
Drug Resistance, Neoplasm
;
Female
;
Glutamates/*therapeutic use
;
Guanine/*analogs & derivatives/therapeutic use
;
Humans
;
Lung Neoplasms/drug therapy/*mortality
;
Male
;
Middle Aged
;
Protein Kinase Inhibitors/*therapeutic use
;
Quinazolines/*therapeutic use
;
Retrospective Studies
;
Survival
;
Treatment Outcome
6.Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea
HyoJeong KIM ; Kyung Ah PARK ; Sei Yeul OH ; Ju Hong MIN ; Byoung Joon KIM
Korean Journal of Ophthalmology 2019;33(1):82-90
PURPOSE: To describe the clinical characteristics and course of optic neuritis (ON) and its association with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Korea. METHODS: In this retrospective case series, 125 eyes of 91 Korean patients with ON were included. The medical documents of adult patients with ON were retrospectively reviewed. Patients were assigned into idiopathic ON, NMOSD, and MS groups according to the presence of an association with NMOSD or MS for subgroup analysis. Clinical characteristics, disease course, and visual and systemic prognosis were analyzed. RESULTS: During the mean follow-up of 3.7 years, 73 patients were diagnosed as idiopathic ON, 14 patients were diagnosed as NMOSD, and four patients developed definite MS. At the final visit, there were 13 (13%) eyes out of 100 eyes with idiopathic ON, nine (43%) eyes out of 21 eyes with NMOSD, and one (25%) eye out of four eyes with MS had a severe visual loss of 20 / 200 or less. The mean Expanded Disability Status Scale was 3.1 ± 1.5 in NMOSD and 1.8 ± 1.5 in the MS group at the final visit. In the NMOSD group, 50% of patients showed severe visual loss in at least one eye or were unable to ambulate without assistance at the final visit (5.3 ± 4.4 years after the initial episode of ON). CONCLUSIONS: Fourteen percent of patients showed positive results for NMO-immunoglobulin G test and 50% of patients with NMOSD showed a severe visual loss in at least one eye or were unable to ambulate without assistance. The proportion of MS was relatively low in Korean ON patients.
Adult
;
Follow-Up Studies
;
Humans
;
Korea
;
Multiple Sclerosis
;
Neuromyelitis Optica
;
Optic Neuritis
;
Prognosis
;
Retrospective Studies
7.Comparison of Obesity Rates in Early Childhood (4 to 80 months) by Parental Socioeconomic Status Using National Cohort Dataset in Korea.
Insook LEE ; Kyung Sook BANG ; Hyojeong MOON ; Jieun KIM
Asian Nursing Research 2016;10(4):305-311
PURPOSE: Child obesity has been on the rise and become a worldwide health issue. Low socioeconomic status (SES) is known as an influencing factor for childhood obesity, but relevant studies on a national level are scarce in Korea. The purpose of this study was to identify the prevalence of obesity for each age group by parental SES and analyze the trends of changes in weight status using a Korean national cohort dataset. METHODS: In Korea, children are eligible for the National Children Health Examination, a mandatory seven-time health checkup for those aged 4 to 80 months. This study tracked 4 to 9-month-old children up to 80 months through seven distinct age groups. A total of 12,362 children had received all seven health exams consecutively. Parental SES was categorized as three stages according to national classifications. Z scores of weight-for-height (for children aged < 24 months) and body mass index (for children aged ≥ 24 months) were used for detecting overweight and obesity. RESULTS: Children with low parental SES showed the highest prevalence of overweight and obesity in all age groups, although there was no consistency in statistical significance. Also, normal and underweight children of 4 to 9 months with low parental SES showed the highest change rate to either overweight or obesity, although no consistency of statistical significance was observed. CONCLUSIONS: Low parental SES can affect the weight status of offspring from early childhood. Thus, early obesity prevention interventions should be provided especially for children in low-income families.
Age Distribution
;
Child
;
Child, Preschool
;
Cohort Studies
;
Cross-Sectional Studies
;
Humans
;
Infant
;
Overweight/epidemiology
;
*Parents
;
Pediatric Obesity/*epidemiology
;
Prevalence
;
Republic of Korea/epidemiology
;
Social Class
8.Fertilization and embryo quality of mature oocytes with specific morphological abnormalities.
Eun Jeong YU ; Hyojeong AHN ; Jang Mi LEE ; Byung Chul JEE ; Seok Hyun KIM
Clinical and Experimental Reproductive Medicine 2015;42(4):156-162
OBJECTIVE: To investigate fertilization and embryo quality of dysmorphic mature oocytes with specific morphological abnormalities obtained from intracytoplasmic sperm injection (ICSI). METHODS: The fertilization rate (FR) and embryo quality were compared among 58 dysmorphic and 42 normal form oocytes (control 1) obtained from 35 consecutive ICSI cycles, each of which yielded at least one dysmorphic mature oocyte, performed over a period of 5 years. The FR and embryo quality of 441 normal form oocytes from another 119 ICSI cycles that did not involve dysmorphic oocytes served as control 2. Dysmorphic oocytes were classified as having a dark cytoplasm, cytoplasmic granularity, cytoplasmic vacuoles, refractile bodies in the cytoplasm, smooth endoplasmic reticulum in the cytoplasm, an oval shape, an abnormal zona pellucida, a large perivitelline space, debris in the perivitelline space, or an abnormal polar body (PB). RESULTS: The overall FR was significantly lower in dysmorphic oocytes than in normal form oocytes in both the control 1 and control 2 groups. However, embryo quality in the dysmorphic oocyte group and the normal form oocyte groups at day 3 was similar. The FR and embryo quality were similar in the oocyte groups with a single abnormality and multiple abnormalities. Specific abnormalities related with a higher percentage of top-quality embryos were dark cytoplasm (66.7%), abnormal PB (50%), and cytoplasmic vacuoles (25%). CONCLUSION: The fertilization potential of dysmorphic oocytes in our study was lower, but their subsequent embryonic development and embryo quality was relatively good. We were able to define several specific abnormalities related with good or poor embryo quality.
Abnormalities, Multiple
;
Cytoplasm
;
Embryonic Development
;
Embryonic Structures*
;
Endoplasmic Reticulum, Smooth
;
Female
;
Fertilization*
;
Oocytes*
;
Polar Bodies
;
Pregnancy
;
Sperm Injections, Intracytoplasmic
;
Vacuoles
;
Zona Pellucida
9.Renal Klotho expression in patients with acute kidney injury is associated with the severity of the injury.
Min Young SEO ; Jihyun YANG ; Jun Yong LEE ; Kitae KIM ; Sun Chul KIM ; Hyojeong CHANG ; Nam Hee WON ; Myung Gyu KIM ; Sang Kyung JO ; Wonyong CHO ; Hyoung Kyu KIM
The Korean Journal of Internal Medicine 2015;30(4):489-495
BACKGROUND/AIMS: The potential physiologic roles of Klotho in acute kidney injury (AKI) have recently been demonstrated in animal models. However, to date, there have been no human studies investigating the expression of renal Klotho in AKI. METHODS: We retrospectively collected biopsy specimens and clinical data of AKI patients between January 2001 and December 2012. Klotho expression was determined by immunohistochemical staining, and the clinical-pathological correlation was examined. RESULTS: Among the 34 patients diagnosed with acute tubular necrosis or acute tubulointerstitial nephritis, 21 patients without chronic histological lesions were included. The mean age was 37.3 +/- 18.5 years and the mean peak creatinine level was 8.2 +/- 5.5 mg/dL. In total, 10 patients (47.6%) received temporary renal replacement therapy (RRT); however, 17 patients (81%) showed functional recovery with creatinine levels of < 1.3 mg/dL after 1 month. The intensity of Klotho expression was scored as a percentage of Klotho-positive area. The renal Klotho score showed a significant negative correlation with the initial or peak creatinine level. When the patients were divided into three groups according to the Klotho score (low, middle, high), the low group had a significantly higher peak creatinine level and a more frequent requirement for RRT. However, the Klotho score was not a significant predictor of renal recovery. CONCLUSIONS: The results demonstrated that renal Klotho expression in humans decreased significantly according to the severity of AKI, regardless of the etiology, and that low expression was associated with a poor short-term outcome.
Acute Kidney Injury/diagnosis/etiology/*metabolism/physiopathology/therapy
;
Adolescent
;
Adult
;
Biomarkers/analysis
;
Biopsy
;
Down-Regulation
;
Female
;
Glucuronidase/*analysis
;
Humans
;
Immunohistochemistry
;
Kidney/*chemistry/pathology/physiopathology
;
Kidney Tubular Necrosis, Acute/diagnosis/etiology/*metabolism/physiopathology/therapy
;
Male
;
Middle Aged
;
Necrosis
;
Predictive Value of Tests
;
Recovery of Function
;
Renal Replacement Therapy
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
Time Factors
;
Treatment Outcome
;
Young Adult
10.Polymicrobial Peritonitis with Lactococcus lactis in a Peritoneal Dialysis Patient
Jun Yong LEE ; Min Young SEO ; Jihyun YANG ; Kitae KIM ; Hyojeong CHANG ; Sun Chul KIM ; Myung Gyu KIM ; Sang Kyung JO ; Wonyong CHO ; Hyoung Kyu KIM
Chonnam Medical Journal 2014;50(2):67-69
Lactococcus lactis (L. lactis) is an important gram-positive bacterium in dairy products. It is a rare cause of opportunistic infections with only four cases of Lactococcus peritoneal dialysis (PD) peritonitis reported in the literature. In Korea, L. lactis infection was first reported in a liver abscess patient in 2010; however, PD peritonitis with Lactococcus has not been reported in Korea. Recently, we experienced a case of Lactococcus-associated polymicrobial PD peritonitis. The patient was initially managed with broad-coverage antibiotics; however, owing to a poor response, the PD catheter was removed and the patient was switched to hemodialysis. We discuss this case and review the literature.
Anti-Bacterial Agents
;
Catheters
;
Dairy Products
;
Humans
;
Korea
;
Lactococcus
;
Lactococcus lactis
;
Liver Abscess
;
Opportunistic Infections
;
Peritoneal Dialysis
;
Peritonitis
;
Renal Dialysis